What is LOPJLB’s current signal on IFRX?

LOPJLB’s latest quantitative signal on InflaRx N.V. (IFRX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IFRX in?

InflaRx N.V. (IFRX) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is InflaRx N.V. based / listed?

InflaRx N.V. is based in DE, listed on NASDAQ.

InflaRx N.V. (IFRX)

COMPARE

Healthcare · Biotechnology · NASDAQ · DE

$1.60+4.58%Close

SELLCRISIS · day 12

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $116M
Beta: 2.61
P/E (TTM): -2.87

Short % float: 22.28%
Days to cover: 26.6
SI change: +2.1%

1W: -6.98%
1M: -21.95%

vs SPY 1W: -8.14%
vs SPY 1M: -24.94%

Industry peers

FMP comparable companies · ranked by market cap

STTKSELLShattuck Labs, Inc.$540MCRISISQ 5$5.97+5.48%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The company's focus on C5a stems from its critical role as an inflammatory mediator…

Employees: 65
Headquarters: DE
Founded: 2017
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 72.2M
Float: 76.8%

inflarx.de ↗

Key executives

Niels C. Riedemann — Co-Founder, Chief Executive Officer & Executive Director

Derval O'Carroll — Senior Vice President and Global Head of Regulatory Affairs & Compliance

Daniel Vetter — Senior Director & Head of IT

SEC filings

EDGAR · CIK 17086880 · IFRX

Analyst consensus

Buy

Bullish1381.3%

Neutral212.5%

Bearish16.3%

L $9.00Avg $9.00H $9.00

Target$9.00+462.50%

Last$1.60

Key stats

Industry peers

Prediction markets

Company news